289 related articles for article (PubMed ID: 33328545)
1. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle.
Zhang C; Han M; Zhang F; Yang X; Du J; Zhang H; Li W; Chen S
Int J Nanomedicine; 2020; 15():885-900. PubMed ID: 32103944
[TBL] [Abstract][Full Text] [Related]
3. Affibody-Conjugated RALA Polymers Delivering Oligomeric 5-Fluorodeoxyuridine for Targeted Therapy of HER2 Overexpressing Gastric Cancer.
Zhang F; Yin J; Zhang C; Han M; Wang X; Fu S; Du J; Zhang H; Li W
Macromol Biosci; 2020 Jul; 20(7):e2000083. PubMed ID: 32558229
[TBL] [Abstract][Full Text] [Related]
4. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
[No Abstract] [Full Text] [Related]
5. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
Mondal L; Mukherjee B; Das K; Bhattacharya S; Dutta D; Chakraborty S; Pal MM; Gaonkar RH; Debnath MC
Int J Nanomedicine; 2019; 14():8073-8094. PubMed ID: 31632019
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
7. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
8. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
9. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
10. Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer.
Zhang C; Fu S; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Nanomaterials (Basel); 2022 Feb; 12(4):. PubMed ID: 35215023
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
Naruphontjirakul P; Viravaidya-Pasuwat K
Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
[No Abstract] [Full Text] [Related]
12. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
[TBL] [Abstract][Full Text] [Related]
13. Chemo/Photoacoustic Dual Therapy with mRNA-Triggered DOX Release and Photoinduced Shockwave Based on a DNA-Gold Nanoplatform.
Zang Y; Wei Y; Shi Y; Chen Q; Xing D
Small; 2016 Feb; 12(6):756-69. PubMed ID: 26683002
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded fucoidan capped gold nanoparticles for drug delivery and photoacoustic imaging.
Manivasagan P; Bharathiraja S; Bui NQ; Jang B; Oh YO; Lim IG; Oh J
Int J Biol Macromol; 2016 Oct; 91():578-88. PubMed ID: 27267570
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
16. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores.
Jang H; Ryoo SR; Kostarelos K; Han SW; Min DH
Biomaterials; 2013 Apr; 34(13):3503-10. PubMed ID: 23395274
[TBL] [Abstract][Full Text] [Related]
17. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
Borker S; Pokharkar V
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
[TBL] [Abstract][Full Text] [Related]
18. DNA-affibody nanoparticles for inhibiting breast cancer cells overexpressing HER2.
Zhang Y; Jiang S; Zhang D; Bai X; Hecht SM; Chen S
Chem Commun (Camb); 2017 Jan; 53(3):573-576. PubMed ID: 27975087
[TBL] [Abstract][Full Text] [Related]
19. Targeted gold nanoshelled hybrid nanocapsules encapsulating doxorubicin for bimodal imaging and near-infrared triggered synergistic therapy of Her2-positve breast cancer.
Dong Q; Wan C; Yang H; Zheng D; Xu L; Zhou Z; Xie S; Du J; Li F
J Biomater Appl; 2020 Sep; 35(3):430-445. PubMed ID: 32515640
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
